- Home
- CRVS vs BGH Comparison
CRVS vs BGH Comparison
Compare CRVS & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- BGH
- Stock Information
- Founded
- CRVS 2014
- BGH 2012
- Country
- CRVS United States
- BGH United States
- Employees
- CRVS N/A
- BGH N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- CRVS Health Care
- BGH Finance
- Exchange
- CRVS Nasdaq
- BGH Nasdaq
- Market Cap
- CRVS 305.4M
- BGH 318.8M
- IPO Year
- CRVS 2016
- BGH N/A
- Fundamental
- Price
- CRVS $5.75
- BGH $16.37
- Analyst Decision
- CRVS Strong Buy
- BGH
- Analyst Count
- CRVS 4
- BGH 0
- Target Price
- CRVS $15.00
- BGH N/A
- AVG Volume (30 Days)
- CRVS 518.7K
- BGH 61.5K
- Earning Date
- CRVS 08-07-2025
- BGH 01-01-0001
- Dividend Yield
- CRVS N/A
- BGH 10.06%
- EPS Growth
- CRVS N/A
- BGH N/A
- EPS
- CRVS N/A
- BGH N/A
- Revenue
- CRVS N/A
- BGH N/A
- Revenue This Year
- CRVS N/A
- BGH N/A
- Revenue Next Year
- CRVS N/A
- BGH N/A
- P/E Ratio
- CRVS N/A
- BGH N/A
- Revenue Growth
- CRVS N/A
- BGH N/A
- 52 Week Low
- CRVS $2.54
- BGH $11.92
- 52 Week High
- CRVS $10.00
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- BGH 63.33
- Support Level
- CRVS $5.28
- BGH $15.76
- Resistance Level
- CRVS $5.64
- BGH $16.43
- Average True Range (ATR)
- CRVS 0.30
- BGH 0.14
- MACD
- CRVS 0.03
- BGH -0.00
- Stochastic Oscillator
- CRVS 77.70
- BGH 91.04
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.